English
English
Tiếng Việt
ภาษาไทย
繁體中文
한국어
Bahasa Indonesia
Español
Português
zu-ZA
0

Market Analysis

European stocks rise on higher results, as Novo Nordisk falls
Amos Simanungkalit · 6.8K Views

16

 

European shares opened higher on Wednesday, buoyed by a series of positive corporate earnings that lifted market sentiment. However, the gains were tempered as heavyweight Novo Nordisk (NYSE) missed its second-quarter operating profit estimates.

The STOXX 600 index across Europe rose by 0.5% to 491.07 points as of 0712 GMT.

The healthcare sub-index saw the largest decline among regional sectors, dropping by 0.7%.

Novo Nordisk's shares fell 6.6% after the company, known for its obesity treatments, reported quarterly operating profit below expectations and reduced its annual profit forecast.

Conversely, shares of Roche increased by 1.5% following reports that the Swiss pharmaceutical giant is considering selling its stake in Flatiron Health.

Among other significant movements, car parts manufacturer Continental surged by 5% after exceeding expectations for its second-quarter results.

In contrast, Puma's shares dropped 12.5% after the German sportswear company lowered its outlook for full-year core profit.

Commerzbank (ETR), one of Germany's prominent banks, fell 5.5% following a 5% decline in its second-quarter net profit.

Beiersdorf's shares slipped nearly 4%, despite the Nivea manufacturer reporting a 7.1% organic sales growth for the first half of the year.

Investors are also anticipating comments from European Central Bank member Olli Rehn and board member Elizabeth McCaul, who are scheduled to speak later in the day.

 

 

 

 

Paraphrasing text from "Reuters" all rights reserved by the original author.

Need Help?
Click Here